Company: JL
Filing Date: 2025-07-28
Form Type: 20-F
Source: 0001213900-25-068049
Chunk: 9

Company: J-Long Group Ltd
Filing Date: 2025-07-28
Form: 20-F
Item: Item 3
Chunk 9
---
 of the issuer’s business activities are carried out in mainland China, or its
main place(s) of business are located in mainland China, or the majority of its senior management team in charge of its business operations
and management are PRC citizens or have their usual place(s) of residence located in mainland China. Where a PRC domestic company is
seeking an indirect overseas offering and listing in an overseas market, the issuer shall designate a major domestic operating entity
responsible for all filing procedures with the CSRC. If a domestic company fails to complete the required filing procedures or conceals
any material fact or falsifies any major content in its filing documents, such domestic company may be subject to administrative penalties,
such as an order to rectify, warnings and fines, and its controlling shareholders, actual controllers, the person directly in charge
and other directly liable persons may also be subject to administrative penalties, such as warnings and fines.

On
May 7, 2024, the CSRC issued the Guidelines of Regulatory Rules Application -- Overseas Offering and Listing No. 7 (“ Guideline
No. 7”), which clarified that domestic companies that submitted an application to transfer from an overseas over-the-counter market
to list on an overseas exchange prior to the effective date of the Trial Measures (March 31, 2023), but that have not yet received approval
from the overseas regulator or stock exchange, must file with the CSRC before their offering and listing procedures are completed. Our
Ordinary Shares were quoted on the Expert Market of OTC Markets and we filed a registration statement with the U. S. Securities and Exchange
Commission (the “ SEC”) for a public offering of our Ordinary Shares and filed an application for listing our Ordinary Shares
on the Nasdaq Stock Market (“ Nasdaq”) prior to the effective date of the Trial Measures, but had not received approval from
the SEC or from Nasdaq as of that date.

The
Company and JLHK are not required to obtain any permissions or approvals pursuant to the Trial Measures, the CSRC Notice and Guideline
7 before issuing our Ordinary Shares to foreign investors or listing on an overseas exchange. Given that our operating revenue, total
profit, total assets or net assets were not derived from PRC domestic companies, the majority of our business activities are not carried
out in mainland China, our main place of business is located in Hong Kong and not in mainland China and the majority of our senior management
team in charge of our business operations and management are